Pre-Eclampsia Clinical Trial
Official title:
Optic Nerve Sheath Diameter Versus Extra-vascular Lung Water Detected by Ultrasound in Volume Status Prediction in Severe Preeclampsia
A quick, non-invasive, bedside test to assess fluid status of patients with severe
preeclampsia would be very helpful to ICU clinicians severe preeclampsia is associated with
an increase in extravascular lung water (EVLW), which can be identified by lung ultrasound
before appearance of clinical signs of pulmonary edema but this technique still requires
several measurements and could be time consuming.
Optic ultrasound is also a safe and repeatable diagnostic tool, which is even quicker and
simpler to perform than lung ultrasound. Increased ONSD is associated with increased ICP and
it can indirectly reflect the state of intracranial edema that could be a part of generalized
edema.
More data on the correlation between ONSD and markers of fluid status (EVLW by ultrasound)
are needed before ONSD measurements can be recommended as a guide to fluid management in
preeclampsia.
Severe preeclampsia (PE) is a progressive multisystem pregnancy disorder. It is considered
the second leading cause of maternal death worldwide. Usually, it is diagnosed by the
new-onset hypertension and either proteinuria or end-organ dysfunction in the second half of
pregnancy.
Acute Pulmonary edema is potentially lethal and is the most common cardiopulmonary
complication of preeclampsia. thus, meticulous fluid management of these patients is crucial
but it is often difficult because the underlying endothelial damage leads to water,
electrolytes, and plasma leakage from the intravascular space which produce significant fluid
shifts into the interstitial space resulting in peripheral and/or central (pulmonary and
central nervous system) edema. Also, there is a potential for hypovolemia due to the
depletion of intravascular volume. Under-resuscitation of preeclampsia patients impairs organ
perfusion; while on the other hand fluid overload leads to tissue edema and aggravates
pulmonary edema. Therefore, fluid administration must be assessed to preserve organ
perfusion, while preventing lung congestion and pulmonary edema.
Early detection of lung congestion would allow early and optimal management of these
patients. Lung ultrasound was reported as a useful diagnostic tool which could identify
increased levels of extravascular lung water (EVLW) in severe PE before clinical signs of
pulmonary edema appear. Consequently, lung ultrasound could guide fluid management and
identify those in need for diuretic therapy among severe PE patients. Though it is considered
accurate, safe, and non-invasive valuable tool, its use could be limited by the need to
several measurements that could be time consuming.
Changes in the Optic Nerve Sheath Diameter (ONSD) detected by ultrasound are considered an
important clinical and radiographic demonstration of increased intracranial pressure (ICP)
which is one of the consequences of preeclampsia. Therefore, Increased ONSD can indirectly
reflect the state of intracranial edema that could be a part of generalized edema.
On ultrasound the ONSD is measured 3 mm posterior to the globe for both eyes. A position of 3
mm behind the globe is recommended because the ultrasound contrast is greatest; the results
are more reproducible and the normal optic nerve sheath measures up to 5.0 mm in diameter. An
average ONSD greater than 5 mm is considered abnormal and elevated intracranial pressure
should be suspected.
Chen et al., studied ONSD and the intravascular volume status of patients after cardiac
surgery and found that changes in ONSD can dynamically reflect changes in volume status in
patients with postoperative cardiac surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03299777 -
Correlation Between Changes in Liver Stiffness and Preeclampsia as Shown by Fibroscan
|
N/A | |
Completed |
NCT03650790 -
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
|
N/A | |
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Not yet recruiting |
NCT03302260 -
Identifying Methods for Postpartum Reduction of Vascular Events: Pilot Randomized Controlled Trial
|
N/A | |
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Completed |
NCT01911494 -
Community Level Interventions for Pre-eclampsia
|
N/A | |
Terminated |
NCT02025426 -
Phenylephrine Versus Ephedrine in Pre-eclampsia
|
Phase 4 | |
Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
Active, not recruiting |
NCT02031393 -
Establishing First Trimester Markers for the Identification of High Risk Twin
|
N/A | |
Terminated |
NCT00141310 -
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
|
Phase 2 | |
Completed |
NCT00157521 -
L-Arginine in Pre-Eclampsia
|
Phase 3 | |
Completed |
NCT04795154 -
Prenatal Yoga as Complementary Therapy of Preeclampsia
|
N/A | |
Completed |
NCT00004399 -
Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia
|
N/A | |
Completed |
NCT00005207 -
Renin and Prorenin in Pregnancy
|
N/A | |
Recruiting |
NCT04551807 -
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
|
Phase 3 | |
Terminated |
NCT04092829 -
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
|
N/A | |
Recruiting |
NCT06067906 -
Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients
|
N/A | |
Recruiting |
NCT06317467 -
Role of Anti-C1q Autoantibodies in Pregnancy
|
||
Completed |
NCT02218931 -
ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
|
N/A | |
Active, not recruiting |
NCT04484766 -
Preeclampsia Associated Vascular Aging
|